27
JUL
2020

Cell Therapy FCR001 to Enter Phase 1/2a Trial for Diffuse Cutaneous SSc

Posted By :
Comments : Off
Cell Therapy FCR001 to Enter Phase 1/2a Trial for Diffuse Cutaneous SSc
Source: Scleroderma AwarePublished on 2020-07-27
About the Author